NEW YORK, June 29, 2026, 15:03 (EDT)
- Astera Labs was up 14.6% to $448.84 after the market opened in the U.S., hitting a high of $452.58.
- UBS Group AG NYSE:UBS put out a Neutral rating with a $400 target on June 29. Shares were trading above that price when the call hit the tape.
- Stifel’s new high target is $460, which is just 2.5% above where shares are now.
Astera Labs, Inc. NASDAQ:ALAB jumped Monday, with the AI-connectivity stock rising well past updated targets on Wall Street. Shares changed hands at $448.84, up $57.10, or 14.6%, at 18:48 UTC, about an hour before the U.S. close.
Astera’s run isn’t only about the rally. UBS Group AG NYSE:UBS bumped its price target to $400 on June 29 from $205 in May, keeping a Neutral rating. By mid-afternoon in New York, Astera traded almost 11% higher than that target.
| Security | Latest price | Day change | Day range | What it says |
|---|---|---|---|---|
| Astera Labs, Inc. NASDAQ:ALAB | $448.84 | +14.6% | $382.00-$452.58 | Astera led among AI infra stocks in this group. |
| Invesco QQQ Trust NASDAQ:QQQ | $723.97 | +2.5% | $705.41-$724.39 | QQQ trailed ALAB by roughly 12 percentage points. |
| VanEck Semiconductor ETF (NASDAQ:SMH) | $632.56 | +3.4% | $596.30-$633.26 | Semis moved up, still well back of ALAB’s run. |
| NVIDIA Corp. NASDAQ:NVDA | $194.00 | +0.8% | $189.98-$196.11 | NVIDIA was up, action stayed muted. |
| Broadcom Inc. NASDAQ:AVGO | $374.81 | +2.7% | $360.55-$376.11 | Broadcom’s gain lagged the chip ETF. |
StockAnalysis.com lists the average 12-month target for Astera at $272.47, which is 39.3% under the most recent price. The same page has a 52-week range of $85.85 to $452.59, so Monday’s high sits right at the top.
| Source | Date | Rating | Target | Gap to $448.84 |
|---|---|---|---|---|
| UBS Group AG NYSE:UBS | June 29 | Neutral | $400 | -10.9% |
| Stifel Financial Corp. NYSE:SF | June 24 | Buy | $460 | +2.5% |
| Bank of America Corp. NYSE:BAC | June 23 | Neutral | $450 | +0.3% |
| Average target, 26 analysts | June 29 | Buy | $272.47 | -39.3% |
Astera’s stock isn’t trading like a typical chip name with a new outlook. Instead, it’s moving like a forced estimate trade. The market is valuing the company at about $81.3 billion on the latest quote. First-quarter revenue came in at $308.4 million, up 93% from last year.
Astera Labs said it expects second-quarter revenue between $355 million and $365 million. With the midpoint at $360 million, the company trades at roughly 56 times annualized second-quarter sales. That’s where investors are focused: they’ll want to see a bigger beat from here to sustain the run.
Astera Labs CEO Jitendra Mohan said in May that first-quarter revenue reached a record $308.4 million. The company said its Scorpio X-Series 320-lane AI fabric switch is now shipping, with production ramping up in the second half of 2026. Astera is targeting a $20 billion merchant scale-up market by 2030.
Astera has an index bid behind it too. Nasdaq Inc. NASDAQ:NDAQ said Astera Labs joined the Nasdaq-100 Index before the open on June 22, along with CoreWeave, Nebius Group, Rocket Lab and Teradyne. Nasdaq said the Nasdaq-100 is tracked by more than 200 investment products with over $800 billion in assets under management.
Astera’s push into Taiwan is something bulls can point to as support for its valuation. Campbell Kan, the company’s VP of Asia sales and Taiwan GM, said earlier this month, “Taiwan is where the global AI supply chain gets built.” Astera has said it’s increasing work with AI platform providers such as Advanced Micro Devices Inc. NASDAQ:AMD, Arm Holdings plc NASDAQ:ARM, Intel Corp. NASDAQ:INTC, and NVIDIA. Astera Labs
The next earnings report is set for Aug. 4. Traders are watching if the June-quarter forecast was too cautious, with shares already trading above Wall Street targets.
